Predictors of Clinical and Neurological Outcome in Traumatic Posterior Fossa Epidural Hematoma
Launched by ASSIUT UNIVERSITY · Feb 21, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying patients who have a specific type of brain injury called traumatic posterior fossa epidural hematoma. This condition occurs when blood collects in a small space at the back of the skull, which can put pressure on the brain and lead to serious problems like difficulty breathing or changes in consciousness. The goal of the study is to understand how well patients recover from this injury and to identify factors that might influence their outcomes.
Anyone of any age who has experienced this type of brain injury may be eligible to participate, but those with spontaneous (non-traumatic) epidural hematomas will not be included. Participants will be monitored to see how they respond to treatment and what factors might affect their recovery. It's important to note that the trial is not yet recruiting participants, so there will be more information available once it begins.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any age
- • Traumatic Posterior fossa epidural hematoma
- Exclusion Criteria:
- • Spontaneous type of epidural heamatoma
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported